Intelligence ยท Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors โ phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text โ searchable for business development and competitive intelligence.
-
Myocardial perfusion imaging
Aspire Biopharma Holdings
Coronary Artery Disease
1 trial -
Naglazyme
BioMarin Pharmaceutical Australia Pty Ltd
Mucopolysaccharidosis VI
1 trial -
Nicotine
BRIGHT MINDS BIOSCIENCES INC.
Marijuana Dependence
1 trial -
Nicotine Nasal Spray
BRIGHT MINDS BIOSCIENCES INC.
Smoking Cessation
1 trial -
Nicotine Patch
BRIGHT MINDS BIOSCIENCES INC.
Cigarette Smoking
3 trials -
Nicotine patch
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
3 trials -
Nicotine patch - transdermal
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
1 trial -
OOPEN+BBCC
BRIGHT MINDS BIOSCIENCES INC.
Opioid Overdose
1 trial -
Oral Methamphetamine
BRIGHT MINDS BIOSCIENCES INC.
HIV-1-infection
1 trial -
Oral consumption
BRIGHT MINDS BIOSCIENCES INC.
Growth Acceleration
1 trial -
Oxycodone
BRIGHT MINDS BIOSCIENCES INC.
Chronic Low Back Pain
1 trial -
PL-ASA
Protalix BioTherapeutics
Healthy Volunteers
1 trial -
Paracetamol Biofarm, 500 mg, tabletki, Placebo - Nalgesin forte, Nalgesin Forte, 550 mg, tabletki powlekane
Novo Nordisk A/S
Knee osteoarthritis
1 trial -
Pegvaliase
BioMarin Pharmaceutical Australia Pty Ltd
Phenylketonuria
1 trial -
Pegylated Interferon
BRIGHT MINDS BIOSCIENCES INC.
Substance-Related Disorders
1 trial -
Pfizer-BioNTech mRNA COVID-19 vaccine
BRIGHT MINDS BIOSCIENCES INC.
COVID -19
1 trial -
Pharmacist Practice Change to Dispense Appropriate Opioid Quantities for Acute Pain
BRIGHT MINDS BIOSCIENCES INC.
Opioid Use
1 trial -
Pharmacotherapy
BRIGHT MINDS BIOSCIENCES INC.
Smoking
1 trial -
Pharmacotherapy for opioid use disorder
BRIGHT MINDS BIOSCIENCES INC.
HIV Infection
1 trial -
Pitolisant
Harmony Biosciences Holdings
Restless Legs Syndrome
1 trial -
Placebo
BRIGHT MINDS BIOSCIENCES INC.
Opioid Dependence
1 trial -
Placebo suspension is identical to Symbioflorยฎ2 liquid formulation in appearance, weight and composition, with the exception that the active ingredient will be omitted. Placebo constitutes are sodium chloride, magnesium sulphate 7H2O, potassium chloride, calcium chloride 2H2O, magnesium chloride 6H2O, and purified water, Symbioflor 2 Tropfen zum Einnehmen, Suspension
Alphapharm Pty Ltd
Irritable Bowel Syndrome
1 trial -
Prednisone Mylan Pharma 5 mg compresse, Prednisone Mylan Pharma 5 mg compresse
Sana Biotechnology
Systemic Lupus Erythematosus
1 trial -
Probiotics
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chronic Kidney Disease
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1โ3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync โ verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources